UPDATE: BridgeBio Pharma (BBIO) PT Lowered to $24 at Goldman Sachs

December 28, 2021 4:02 AM EST Send to a Friend
(Updated - December 28, 2021 4:02 AM EST)

Goldman Sachs analyst Paul Choi lowered the price target on BridgeBio ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login